NCT06760507

Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2025-02-01Est. Completion: 2028-06-30

Enrollment target: 3,209 participants

Locations

Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Contact

Yue Guan, PhDyue.guan@emory.edu 404-712-1671

Other microbiome trials you might be interested in

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerPhase 3Recruiting

Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8

This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatm…

Anchorage, United StatesEst. completion Dec 31, 2026

View Trial →

Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up StudyCompleted

Breast Cancer

This study will explore new screening methods for early detection of breast and ovarian cancer in women at high risk for…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.